The article names VK2735 from Viking Therapeutics, described as a dual GIP and GLP-1 agonist in late-stage trials, and retatrutide from Eli Lilly, a triple GIP, GLP-1 and glucagon receptor agonist in clinical development
Atrophic gastritis is common in older adults and quietly reduces B12 absorption from food
Future research will determine whether GLP-1 drugs can become a mainstay in treating neurological and psychiatric conditions alongside traditional therapies
Even with insurance, some people still pay high co-pays or deductibles
The alleviation of symptoms that are treated through vitamin B12 injections including fatigue and lethargy can start to be noticed after a few days and will continue to improve for multiple weeks
Pearson correlations examined relationships between thalamic GSH (left and right thalamus, analysed separately) and clinical variables within the migraine group (five variables: disease duration, attack frequency, VAS, MIDAS, HIT-6) and within the TTH group (four variables: disease duration, attack frequency, VAS, HIT-6